Astellas Pharma
$11.13
24H
Market Cap
Volume
Supply
Price Chart
About Astellas Pharma - ALPMF
Astellas Pharma is a Japanese multinational pharmaceutical company that develops and markets drugs for various therapeutic areas, including urology, immunology, and oncology. It was formed from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. in April 2005.
What are Astellas Pharma's core values and mission statement?
Astellas Pharma's core values revolve around being patient-focused, conducting business with integrity, showing respect for individuals, and aiming to produce better results through teamwork. Their mission is to improve the health of people around the world through innovative and reliable pharmaceutical products.
Who founded Astellas Pharma and when?
ASTELLAS PHARMA was founded through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. on April 1, 2005.
Who leads Astellas Pharma?
The leadership of Astellas Pharma is typically headed by a Chief Executive Officer (CEO), but the specific individual holding this position may change over time, reflecting internal promotions, retirements, or new appointments.
Where is Astellas Pharma located, and what is its base country?
Astellas Pharma has its headquarters in Tokyo, Japan.
On which exchanges is Astellas Pharma traded?
Astellas Pharma Inc. is primarily listed and traded on the Tokyo Stock Exchange in Japan.
Historical data
Astellas Pharma (ALPMF) Price Live Data
The live price of Astellas Pharma (ALPMF) is $11.13, with a trading volume of 575 in the last 24 hours. Wrapstocks updates the ALPMF price in real-time. Astellas Pharma is up 0% in the last 24 hours. The company has a live market cap of $20,045,352,960.00 and a supply of 1,801,020,032 ALPMF stocks.
Astellas Pharma (ALPMF) is traded on OTC Markets U.S., and currently, the market is closed; trading will be resumed in 3 hours and 27 minutes.
